Immupharma Share Discussion Threads

[nobbygnome] 07/12/2018 07:34

Well a completely nothing announcement this morning; no wonder they put it out on a Friday. But never mind, the board will keep on taking their big salaries wasting your shareholder funds whilst doing virtually nothing. You shareholder should be agitating for changes on the board and some real action.

It is all so sad....and predictable!

[fuji99] 05/12/2018 12:52

No I don't and I don't want to be a guinea pig.

[stockriser] 05/12/2018 09:07

"and their stupidity in giving placebo to desperate poor people"

Do you actually understand what a placebo is, and why it is used in clinical trials?

[fuji99] 05/12/2018 08:57

Due to their previous "clarity" in everything and their stupidity in giving placebo to desperate poor people, never believe whatever they say anymore. Expect a fund raising exercise to dilute the share price to reach 1 - 2 p to become insolvent then vanish.

[ken chung] 03/12/2018 13:52

Classic pile of worthless dog dung heading for 4p.

Lemmings and mushrooms only now.

[troajan1] 03/12/2018 11:19

Talk of fantastic news this week

[michbens] 30/11/2018 14:26

Pump over...

[fillipe] 30/11/2018 10:52

Mmmm....gone off the boil, 1030hrs, onwards.

f

[mister md] 30/11/2018 08:22

It needs positive news for a 'real' rise - at the moment its just pi buys leading to additional AT robot buys and sells leading to robot sells imho

[amadeus888] 30/11/2018 07:16

This is due a rise?

[top tips] 30/11/2018 00:54

Is it game is on again?

[colsmith] 29/11/2018 17:21

SK - interesting view thanks; not sure of any of the 3 but share price move interesting.

[knowing] 29/11/2018 16:08

I'm liking this

[fillipe] 29/11/2018 16:06

IMM certainly being well taken with very close to the ask of 14p now being regularly paid.

Weekend press?

f
P.S. make that 14.95p showing as the lowest ask....L2.

f

[glennrcharles] 29/11/2018 13:20

I'll take 1 and 2...so it's probably 3 lol

[joeblogg2] 29/11/2018 13:18

Lets hope 1 and 2 !!! Bought a modest holding back again after losing over £10k last time after the mixed results.

[sicilian_kan] 29/11/2018 13:14

Well the share price is looking perky. In my view there are three possible reasons:

1. Shareholder anticipation of a Ureka deal. NASH is a hot pharma area at the moment. It was announced yesterday that Genentech bought Jecure Therapeutics. See the very interesting article below about the Pharma race to acquire NASH



"Roche has joined the melee of pharma companies trying to claim a share of the market for non-alcoholic steatohepatitis (NASH) drugs, cutting a deal to acquire US start-up Jecure Therapeutics."

"NASH is a hot topic in pharma development at the moment, with a host of companies vying to bring forward new treatments for the disease, which is viewed as an emerging health crisis - and an untapped pharma market."

"Some predictions put the market potential at $20bn to $35bn a year."

Now we know from the Interims that:

"Ureka, ImmuPharma's wholly owned subsidiary, based in Bordeaux, which is carrying out research into treatments for Type II diabetes and NASH (Non-Alcoholic-Steato-Hepatitis) has recently demonstrated success in recognised preclinical studies.

Following an extensive review by ImmuPharma's Board of directors, it has been decided that Ureka, whilst having exciting and innovative technologies, is not part of the ongoing strategy of ImmuPharma, which is now fully focused on utilising its resources to develop late stage assets.

As such, ImmuPharma, with its advisors, will now commence a process of considering all opportunities to divest Ureka. The intention is to allow ImmuPharma to divest Ureka, whilst still retaining an interest in any future commercial success."

2) Shareholder anticipation of more Lupuzor news.

YoungHarry has stated "Mid November / early December, full analyses of PIII trial" and

"The company will receive the full data from the PIII trial by the of end July / mid August, analysis will take a further two months and answers to key research issues will take a further two months after that. The key research findings will be published in peer reviewed journals."

3) Misplaced shareholder anticipation


Take your pick.

[michbens] 29/11/2018 12:50

No doubt it's another pump and dump..Just look at Twitter. Same old characters are back in after it dropped to 10p.Suddently the rumours reappear after a 5 day period of silence

[glennrcharles] 29/11/2018 12:21

Ok why all the buys. Are we expecting anything.. ever?

[nobbygnome] 29/11/2018 09:05

>> s_k

All fine as far as it goes. However, again they have used a concentration of peptide which will never be reached in vivo (10uM). So the results are completely meaningless for any mode of action in patients at the current dose!

[oldvic] 29/11/2018 08:56

why only 2 thousand shares traded so far today?

[sicilian_kan] 28/11/2018 09:24

There are a number of interesting articles on autophagy, P140 / Lupuzor in the past few months:







Abstracts available in the above. The full text articles are also an interesting read if you have access.

[fillipe] 28/11/2018 08:44

Well worth picking up in the 11's, as a lock-away for eventual future news.
I've done so, this morning and have also done so in the past, to good effect.

f

[ken chung] 28/11/2018 08:23

Just a lifestyle company now until the cash runs out paying the management salaries six figure salaries.Worthless.